Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Original Research

Published on 04 Sep 2024

Current status and influencing factors of prophylactic use of proton pump inhibitors in internal medicine inpatients receiving glucocorticoid therapy

in Gastrointestinal and Hepatic Pharmacology

Pengpeng Liu
Guangyao Li
Qian Wu
Mei Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418086

2,611 views
1 citation

Review

Published on 03 Sep 2024

Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: a review

in Gastrointestinal and Hepatic Pharmacology

Yalan Deng
Yuan Dong
Sitian Zhang
Yingmei Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1463187

5,398 views
12 citations

Original Research

Published on 03 Sep 2024

The different effects of four adenosine receptors in liver fibrosis

in Gastrointestinal and Hepatic Pharmacology

Lan Yang
Zhao-wei Gao
Xi Wang
Xia-nan Wu
Si-min Li
Ke Dong
Xiao-ming Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424624

2,835 views
2 citations

Original Research

Published on 02 Sep 2024

Exploring the top 30 drugs associated with drug-induced constipation based on the FDA adverse event reporting system

in Gastrointestinal and Hepatic Pharmacology

Wenwen Li
Cuncheng Liu
Zhongyi Zhang
Zhikai Cai
Tailong Lv
Ruiyuan Zhang
Yaoyao Zuo
Shouqiang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443555

5,401 views
5 citations

Original Research

Published on 27 Aug 2024

Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn’s disease

in Gastrointestinal and Hepatic Pharmacology

Kouzhu Zhu
Xiaoliang Ding
Ling Xue
Linsheng Liu
Yan Wang
Yun Li
Qinhua Xi
Xueqin Pang
Weichang Chen
Liyan Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430120

2,259 views
2 citations

Brief Research Report

Published on 19 Aug 2024

The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function

in Gastrointestinal and Hepatic Pharmacology

Sohini Sikdar
Debmalya Mitra
Oishika Das
Moumita Bhaumik
Shanta Dutta

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407228

3,905 views
2 citations

Brief Research Report

Published on 16 Aug 2024

Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy

in Gastrointestinal and Hepatic Pharmacology

Shike Lou
Xiaoyin Wang
Fei Yuan
Gangde Zhao
Mingyang Feng
Yezhou Ding
Lanyi Lin
Kehui Liu
Xiaolin Wang
Wanqing Chi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453595

2,617 views
2 citations

Correction

Published on 15 Aug 2024

Corrigendum: YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

in Gastrointestinal and Hepatic Pharmacology

Zhan Jing-Lun
Chai Shuang
Zhao Li-Mei
Liu Xiao-Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395496

1,065 views

Systematic Review

Published on 15 Aug 2024

Effects of perioperative steroid use on surgical stress and prognosis in patients undergoing hepatectomy: a systematic review and meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Furui Zhong
Hua Yang
Xuefeng Peng
Kerui Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415011

1,791 views
1 citation

Original Research

Published on 13 Aug 2024

CPS1 augments hepatic glucagon response through CaMKII/FOXO1 pathway

in Gastrointestinal and Hepatic Pharmacology

Xiao-Meng Sun
Xin Wu
Meng-Guang Wei
Li-Zeng Zhu
Wen-hui Wu
Xin-Yue Zhou
Lian-Wen Qi
Qun Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437738

3,202 views
2 citations

Original Research

Published on 13 Aug 2024

Thonningianin A ameliorated renal interstitial fibrosis in diabetic nephropathy mice by modulating gut microbiota dysbiosis and repressing inflammation

in Gastrointestinal and Hepatic Pharmacology

Shujiao Zhang
Shuaixing Zhang
Xuehui Bai
Yaoxian Wang
Yuning Liu
Weijing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389654

4,541 views
11 citations

Review

Published on 06 Aug 2024

Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges

in Gastrointestinal and Hepatic Pharmacology

Ying Yang
Xiaojing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419384

5,612 views
8 citations

Original Research

Published on 31 Jul 2024

Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis

in Gastrointestinal and Hepatic Pharmacology

Miaomiao Yang
Xiongying Jiang
Huan Liu
Qingyu Zhang
Jing Li
Li Shao
Lei Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410767

2,291 views
5 citations

Original Research

Published on 31 Jul 2024

The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis

in Gastrointestinal and Hepatic Pharmacology

Paolo Comeglio
Giulia Guarnieri
Sandra Filippi
Ilaria Cellai
Gabriele Acciai
Ian Holyer
Fredrik Zetterberg
Hakon Leffler
Barbro Kahl-Knutson
Erica Sarchielli

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430109

4,672 views
8 citations

Original Research

Published on 31 Jul 2024

Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD

in Gastrointestinal and Hepatic Pharmacology

Ang Huang
Cailun Zou
Zhe Dai
Ying Sun
Jing Wang
Shuhong Liu
Lin Han
Songhai Chen
Qingsheng Liang
Chunyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437479

2,749 views
4 citations

Systematic Review

Published on 31 Jul 2024

Single and combined strategies for mesenchymal stem cell exosomes alleviate liver fibrosis: a systematic review and meta-analysis of preclinical animal models

in Gastrointestinal and Hepatic Pharmacology

Xiaolei Zhou
Yan Xu
Xuesong Wang
Wenming Lu
Xingkun Tang
Yu Jin
Junsong Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432683

4,335 views
5 citations

Original Research

Published on 30 Jul 2024

A scientometrics analysis and visualization of refractory gastroesophageal reflux disease

in Gastrointestinal and Hepatic Pharmacology

Nan Zhang
Ming Han
Qin-Wei Zheng
Meng-Yuan Zhang
Wen-Lan Zhi
Jing-Jing Li
Lin-Xuan Cui
Jin-Li Tian
Yi Wang
Sheng-Quan Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393526

3,488 views
1 citation

Systematic Review

Published on 29 Jul 2024

A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection

in Gastrointestinal and Hepatic Pharmacology

Lingbo Hu
Chao Yang
Yingli Qiao
Aidong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443551

2,502 views

Original Research

Published on 29 Jul 2024

Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response

in Gastrointestinal and Hepatic Pharmacology

Long Shu
Hangjie Fu
Aiwen Pi
Yuliang Feng
Hui Dong
Caijuan Si
Songtao Li
Feiye Zhu
Peifen Zheng
Qin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424219

4,974 views
20 citations

Review

Published on 26 Jul 2024

Exploring the gut microbiota’s crucial role in acute pancreatitis and the novel therapeutic potential of derived extracellular vesicles

in Gastrointestinal and Hepatic Pharmacology

Yijie Li
Jie Li
Sen Li
Shumin Zhou
Jiahua Yang
Ke Xu
Yafeng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437894

4,481 views
4 citations

Original Research

Published on 26 Jul 2024

Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

in Gastrointestinal and Hepatic Pharmacology

Yanni Li
Yaoyu Guo
Chong Geng
Shuailing Song
Wenjuan Yang
Xiao Li
Chunhui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1421577

4,282 views
8 citations

Review

Published on 22 Jul 2024

Efficacy and safety of peroxisome proliferator-activated receptor agonists for the treatment of primary biliary cholangitis: a meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Gang Tang
Jie Zhang
Linyu Zhang
Lingying Xia
Xiaojuan Tang
Rui Chen
Rongxing Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432814

3,531 views
3 citations

Original Research

Published on 19 Jul 2024

Revealing the role of metformin in gastric intestinal metaplasia treatment

in Gastrointestinal and Hepatic Pharmacology

Ruoyu Hu
Xia Xue
Xiangdong Sun
Yang Mi
Huijuan Wen
Huayuan Xi
Fuhao Li
Pengyuan Zheng
Simeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1340309

6,844 views
8 citations

Original Research

Published on 17 Jul 2024

Platycodon D reduces obesity and non-alcoholic fatty liver disease induced by a high-fat diet through inhibiting intestinal fat absorption

in Gastrointestinal and Hepatic Pharmacology

Xingkui Tang
Yi Yang
Wenxu Peng
Mengping Xu
Qitong Fan
Feng Li
Guorong Zou
Jianlin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412453

4,787 views
6 citations

1,288 articles

articles

Current status and influencing factors of prophylactic use of proton pump inhibitors in internal medicine inpatients receiving glucocorticoid therapy

Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: a review

The different effects of four adenosine receptors in liver fibrosis

Exploring the top 30 drugs associated with drug-induced constipation based on the FDA adverse event reporting system

Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn’s disease

The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function

Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy

Corrigendum: YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

Effects of perioperative steroid use on surgical stress and prognosis in patients undergoing hepatectomy: a systematic review and meta-analysis of randomized controlled trials

CPS1 augments hepatic glucagon response through CaMKII/FOXO1 pathway

Thonningianin A ameliorated renal interstitial fibrosis in diabetic nephropathy mice by modulating gut microbiota dysbiosis and repressing inflammation

Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges

Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis

The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis

Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD

Single and combined strategies for mesenchymal stem cell exosomes alleviate liver fibrosis: a systematic review and meta-analysis of preclinical animal models

A scientometrics analysis and visualization of refractory gastroesophageal reflux disease

A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection

Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response

Exploring the gut microbiota’s crucial role in acute pancreatitis and the novel therapeutic potential of derived extracellular vesicles

Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

Efficacy and safety of peroxisome proliferator-activated receptor agonists for the treatment of primary biliary cholangitis: a meta-analysis of randomized controlled trials

Revealing the role of metformin in gastric intestinal metaplasia treatment

Platycodon D reduces obesity and non-alcoholic fatty liver disease induced by a high-fat diet through inhibiting intestinal fat absorption